Expand All IND Program The IND program home page is intended to provide information for IND committee members, Disease site and IND study chairs on what is happening in the IND program, including current protocols, drugs and pipelines under discussion, agendas and minutes as well as a portal to submit proposals/LOIs and pose questions. Go to Site Investigational New Drug (IND) Committee Overview The IND Committee advises the Director of the IND Program on policy matters and the overall direction of new drug studies, and to that extent serves as an extension of the Clinical Trials Committee and as a standing modality committee. Membership of the IND Committee is largely determined, however, by phase I and II study participation. Members are expected to represent the views of their centres regarding interest and feasibility in proposed studies and serve as conduits for communication within their centres. IND Disease Site Committee Information for the IND Disease Site Committee. Go to Committee
